|
|
|
|
| LEADER |
01663nmm a2200361 u 4500 |
| 001 |
EB001871979 |
| 003 |
EBX01000000000000001035350 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
190824 ||| eng |
| 100 |
1 |
|
|a Wacker, Daniel
|
| 245 |
0 |
0 |
|a Structural basis of LSD signaling
|h Elektronische Ressource
|c Daniel Wacker
|
| 246 |
3 |
1 |
|a Structural basis of LSD signalling
|
| 260 |
|
|
|a London
|b Henry Stewart Talks
|c 2019, 2019
|
| 300 |
|
|
|a 1 streaming video file (31 min.)
|b color, sound
|
| 505 |
0 |
|
|a Lysergic Acid Diethylamide (LSD) history, physiological effects, and utility -- G Protein-coupled serotonin receptor signalling -- Structure of LSD-bound serotonin receptor -- Uniquely slow LSD binding kinetics -- Binding kinetics are linked to LSD’s pharmacological properties
|
| 653 |
|
|
|a LSD (Drug) / Pharmacology
|
| 653 |
|
|
|a LSD (Drug) / Physiological effect
|
| 653 |
|
|
|a Receptors, G-Protein-Coupled
|
| 653 |
|
|
|a Signal Transduction
|
| 653 |
|
|
|a Cellular signal transduction
|
| 653 |
|
|
|a G proteins / Receptors
|
| 653 |
|
|
|a Lysergic Acid Diethylamide / chemistry
|
| 653 |
|
|
|a Lysergic Acid Diethylamide / pharmacology
|
| 653 |
|
|
|a Receptors, Serotonin
|
| 653 |
|
|
|a Binding Sites
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b HST
|a Henry Stewart Talks
|
| 490 |
0 |
|
|a Structural and functional insights into GPCR signalling
|
| 500 |
|
|
|a Animated audio-visual presentation with synchronized narration. - Title from title frames. - Mode of access: World Wide Web
|
| 856 |
4 |
0 |
|u https://hstalks.com/bs/4000
|x Verlag
|z Streaming video file
|
| 856 |
4 |
2 |
|u https://hstalks.com/bs/p/1050
|3 Series
|
| 082 |
0 |
|
|a 570
|